Clinical trial NCT02936271 - References

Varicose Veins — Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting

Citation(s)

•   Bergan JJ
  Chronic venous insufficiency and the therapeutic effects of Daflon 500 mg. Angiology. 2005 Sep-Oct;56 Suppl 1:S21-4. Review.
•   Bogachev VIu, Golovanova OV, Kuzhetsov AN, Shekoian AO
  [On advisability of perioperative phleboprotection in endovascular treatment of lower in varicose disease: first initial results of the decision study]. Angiol Sosud Khir. 2012;18(2):90-5. Russian.
•   Brand FN, Dannenberg AL, Abbott RD, Kannel WB
  The epidemiology of varicose veins: the Framingham Study. Am J Prev Med. 1988 Mar-Apr;4(2):96-101.
•   Callam MJ
  Epidemiology of varicose veins. Br J Surg. 1994 Feb;81(2):167-73. Review.
•   de Souza Md, Cyrino FZ, Mayall MR, Virgini-Magalhães CE, Sicuro FL, de Carvalho JJ, Verbeuren TJ, Bouskela E
  Beneficial effects of the micronized purified flavonoid fraction (MPFF, Daflon® 500 mg) on microvascular damage elicited by sclerotherapy. Phlebology. 2016 Feb;31(1):50-6. doi: 10.1177/0268355514564414. Epub 2014 Dec 15.
•   International Task Force
  The management of chronic venous disorders of the leg: an evidence-based report of an international task force. Epidemiology. Phlebology. 1999;14(suppl 1):23-34.
•   Lyseng-Williamson KA, Perry CM
  Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs. 2003;63(1):71-100. Review.
•   Ramelet AA
  Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology. 2001 Aug;52 Suppl 1:S49-56. Review.
•   Shoab SS, Scurr JH, Coleridge-Smith PD
  Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction - a pilot study. Eur J Vasc Endovasc Surg. 1999 Oct;18(4):334-8.
•   Tsimoyiannis EC, Floras G, Antoniou N, Papanikolaou N, Siakas P, Tassis A
  Low-molecular-weight heparins and Daflon for prevention of postoperative thromboembolism. World J Surg. 1996 Oct;20(8):968-71; discussion 972.
•   Zahariev T, Anastassov V, Girov K, Goranova E, Grozdinski L, Kniajev V, Stankev M
  Prevalence of primary chronic venous disease: the Bulgarian experience. Int Angiol. 2009 Aug;28(4):303-10.

Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting.

Details for clinical trial NCT02936271